You have 9 free searches left this month | for more free features.

Preleukemia

Showing 1 - 25 of 1,392

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Samples of Bone Marrow Aspiration From Myelodysplastic Syndrome

Recruiting
  • Myelodysplastic Syndromes
  • Blood test
  • Jerusalem, Israel
    Shaare Zedek Medical Center
Nov 27, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

Active, not recruiting
  • Myelodysplastic Syndromes
  • cyclophosphamide, fludarabine, and antithymocyte globulin
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Luspatercept in Korean Myelodysplastic Syndrome or ß-thalassemia

Not yet recruiting
  • Myelodysplastic Syndrome
  • Beta Thalassemia
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome

Not yet recruiting
  • Acute Leukemia
  • Myelodysplastic Syndromes
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 5, 2023

    MDS Trial (Imetelstat)

    Available
    • Myelodysplastic Syndromes
    • (no location specified)
    Jun 30, 2023

    MDS Trial run by the National Cancer Institute (NCI) (KPT-8602, Inqovi)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 30, 2023

    iN the Real Practice

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Vyxeos liposomal
    • Roma, Italy
      Policlinico Tor Vergata
    Nov 16, 2023

    MDS Trial (Yisui granule, Placebo)

    Not yet recruiting
    • MDS
    • Yisui granule
    • Placebo
    • (no location specified)
    Jan 13, 2023

    Lower-risk Myelodysplastic Syndrome Trial in Tampa (JSP191)

    Recruiting
    • Lower-risk Myelodysplastic Syndrome
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 20, 2023

    MDS Trial in Hefei (Unrelated Umbilical Cord Blood, Venetoclax, Decetabine)

    Recruiting
    • Myelodysplastic Syndromes
    • Unrelated Umbilical Cord Blood
    • +3 more
    • Hefei, Anhui, China
      The First Affiliated Hospital of University of Science and Techn
    Oct 27, 2023

    MDS Trial in Hangzhou (IV Decitabine, Decitabine and cedazuridine, only Decitabine and cedazuridine)

    Recruiting
    • Myelodysplastic Syndromes
    • IV Decitabine
    • +2 more
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital,Zhejiang University School of Medi
    Oct 23, 2023

    Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • High-Risk and Very High-Risk Myelodysplastic Syndromes
    • (no location specified)
    Jul 25, 2023

    MDS, Ferroptosis Trial in Pessac (Biological sampling)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Ferroptosis
    • Biological sampling
    • Pessac, France
    • +2 more
    Jun 19, 2023

    MDS Trial in Beijing (Roxadustat, Luspatercept)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 17, 2023

    High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

    Recruiting
    • High Grade Myelodysplastic Syndromes
    • Aurora, Colorado
      Universtiy of Colorado Denver
    Nov 17, 2022

    Biospecimen Acquisition for Myelodysplastic Syndromes

    Recruiting
    • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 20, 2022

      MDS Trial (Decitabine/Cedazuridine, Magrolimab)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • (no location specified)
      Apr 18, 2023

      Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • (no location specified)
      Sep 18, 2023

      MDS Trial run by the National Cancer Institute (NCI) (decitabine and cedazuridine, BMS-986253)

      Not yet recruiting
      • Myelodysplastic Syndromes
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

      Recruiting
      • Myelodysplastic Syndromes
      • Chronic Myelomonocytic Leukemia
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital, Chinese Acade
      Jul 30, 2023

      Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

      Available
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Galinpepimut-S
      • (no location specified)
      Oct 20, 2022

      Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

      Completed
      • Myelodysplastic Syndrome
      • SyB L-1101
      • Nagoya, Aichi, Japan
      • +2 more
      Nov 14, 2022

      Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Neoplasm
      • (no location specified)
      Apr 24, 2023